Although the mechanisms/pathways by which ACE inhibitors affect myocardial fibrosis are complex, angiotensin II was shown to stimulate fibroblast proliferation and ECM synthesis through the TGF-β pathway82–84— a key regulator of collagen synthesis. This evidence concerns the gene TGFB1 and Myocardial fibrosis.